Baidu
map

Diabetes Care:2月大时糖尿病孕妇的宝宝体重开始超标

2016-05-22 MedSci MedSci原创

发表在Diabetes Care的一项研究表明,患有妊娠期糖尿病的产妇分娩的婴儿即便护理良好和采用母乳喂养,即便宝宝们出生时没有脂肪含量的差异,但他们在2-3月大时仍然比正常婴儿胖16%。这项研究首次发现,妊娠期糖尿病女性分娩的婴儿在出生数月内较正常婴儿体重增加更多。这项研究表明婴儿母亲妊娠期糖尿病有更大的脂肪组织在早期阶段,这可能是许多健康问题的先兆。伦敦帝国理工学院的Karen Logan博士

发表在Diabetes Care的一项研究表明,患有妊娠期糖尿病的产妇分娩的婴儿即便护理良好和采用母乳喂养,即便宝宝们出生时没有脂肪含量的差异,但他们在2-3月大时仍然比正常婴儿胖16%。这项研究首次发现,妊娠期糖尿病女性分娩的婴儿在出生数月内较正常婴儿体重增加更多。这项研究表明婴儿母亲妊娠期糖尿病有更大的脂肪组织在早期阶段,这可能是许多健康问题的先兆。

伦敦帝国理工学院的Karen Logan博士指出,这表明妊娠糖尿病产妇分娩的婴儿较正常婴儿有更多的脂肪组织,因此今后可能会出现更多的健康问题。

既往研究表明妊娠期糖尿病与与后代肥胖和超重有关。最近发表的一项研究指出,妊娠糖尿病和(或)怀孕期间体重增加过多会增加后代10年内的肥胖风险,即使婴儿出生时体重正常,在10年内他们的肥胖风险依旧存在且高于常人。

Logan博士指出,这项研究利用MRI直接测量宝宝脂肪组织含量。共有86名2011年10月-2014年10月出生在切尔西和威斯敏斯特医院的婴儿参与研究。实验组宝宝的母亲患有妊娠期糖尿病(42人),对照组为普通宝宝(44人)。当婴儿出生8-12周时研究人员通过MRI对他们进行全身扫描以评估他们全身脂肪组织含量和肝内脂肪含量。

妊娠期糖尿病女性血糖控制良好,妊娠晚期平均糖化血红蛋白水平为5.3%。大多数婴儿采用母乳喂养,时长为8-12个月(实验组:71%,对照组:74%)。

约11天大时,对照组和实验组宝宝的脂肪总量相似(P=0.55)。10周后实验组婴儿的脂肪总量明显高于对照组(P=0.01)。调整新生儿体重后结论依旧成立(16.0%, P =0.002)。两组宝宝肝脏脂肪含量及分布无明显差异。研究人员认为母亲是否患有妊娠期糖尿病与宝宝今后体重变化有明显关系。但他们表示仍需进行更进一步的研究。

原始出处:
Mothers With Gestational Diabetes Have Fatter Babies at 2 Months,Medscape,19,May,2016

Development of Early Adiposity in Infants of Mothers With Gestational Diabetes Mellitus,Karen M. Logan,et al,Diabetes Care. May 12, 2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1637340, encodeId=ab75163e34006, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Sep 12 21:10:00 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759674, encodeId=38931e5967473, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jun 07 07:10:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901381, encodeId=cb0a1901381e0, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jul 18 01:10:00 CST 2016, time=2016-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88172, encodeId=ee8e881e23f, content=好文章,得多学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Thu Jun 02 02:46:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249692, encodeId=1ca3124969236, content=<a href='/topic/show?id=95264599452' target=_blank style='color:#2F92EE;'>#宝宝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45994, encryptionId=95264599452, topicName=宝宝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=杏林小小, createdTime=Sun May 22 11:10:00 CST 2016, time=2016-05-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1637340, encodeId=ab75163e34006, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Sep 12 21:10:00 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759674, encodeId=38931e5967473, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jun 07 07:10:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901381, encodeId=cb0a1901381e0, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jul 18 01:10:00 CST 2016, time=2016-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88172, encodeId=ee8e881e23f, content=好文章,得多学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Thu Jun 02 02:46:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249692, encodeId=1ca3124969236, content=<a href='/topic/show?id=95264599452' target=_blank style='color:#2F92EE;'>#宝宝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45994, encryptionId=95264599452, topicName=宝宝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=杏林小小, createdTime=Sun May 22 11:10:00 CST 2016, time=2016-05-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1637340, encodeId=ab75163e34006, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Sep 12 21:10:00 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759674, encodeId=38931e5967473, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jun 07 07:10:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901381, encodeId=cb0a1901381e0, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jul 18 01:10:00 CST 2016, time=2016-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88172, encodeId=ee8e881e23f, content=好文章,得多学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Thu Jun 02 02:46:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249692, encodeId=1ca3124969236, content=<a href='/topic/show?id=95264599452' target=_blank style='color:#2F92EE;'>#宝宝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45994, encryptionId=95264599452, topicName=宝宝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=杏林小小, createdTime=Sun May 22 11:10:00 CST 2016, time=2016-05-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1637340, encodeId=ab75163e34006, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Sep 12 21:10:00 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759674, encodeId=38931e5967473, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jun 07 07:10:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901381, encodeId=cb0a1901381e0, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jul 18 01:10:00 CST 2016, time=2016-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88172, encodeId=ee8e881e23f, content=好文章,得多学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Thu Jun 02 02:46:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249692, encodeId=1ca3124969236, content=<a href='/topic/show?id=95264599452' target=_blank style='color:#2F92EE;'>#宝宝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45994, encryptionId=95264599452, topicName=宝宝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=杏林小小, createdTime=Sun May 22 11:10:00 CST 2016, time=2016-05-22, status=1, ipAttribution=)]
    2016-06-02 沉心多思

    好文章,得多学习了!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1637340, encodeId=ab75163e34006, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Sep 12 21:10:00 CST 2016, time=2016-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759674, encodeId=38931e5967473, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jun 07 07:10:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901381, encodeId=cb0a1901381e0, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jul 18 01:10:00 CST 2016, time=2016-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88172, encodeId=ee8e881e23f, content=好文章,得多学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Thu Jun 02 02:46:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249692, encodeId=1ca3124969236, content=<a href='/topic/show?id=95264599452' target=_blank style='color:#2F92EE;'>#宝宝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45994, encryptionId=95264599452, topicName=宝宝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=杏林小小, createdTime=Sun May 22 11:10:00 CST 2016, time=2016-05-22, status=1, ipAttribution=)]

相关资讯

Nat Commun:干细胞疗法治疗糖尿病日渐成熟 科学家已经实现利用病人组织获得β细胞

(上图表明病人组织来源β细胞与正常人组织来源β细胞的分子标记无差异)   最近,来自华盛顿大学医学院和哈佛大学的研究人员利用1型糖尿病病人组织形成的诱导多能干细胞分化得到具有胰岛素分泌功能的β细胞,为治疗糖尿病找到一个新的潜在方法。1型糖尿病病人自身无法合成胰岛素,因此需要常规注射胰岛素帮助控制血糖。这项最新发现表明糖尿病个体化治疗已见曙光。   相关研究结果发表在

JACC:替卡格雷治疗糖尿病患者,降低缺血事件发生

背景:糖尿病患者与动脉粥样硬化事件发生的风险升高相关。目标:确定对存在心肌梗死病史(MI)的糖尿病患者,应用替卡格雷抗血小板治疗对复发性缺血事件的影响。方法:研究者将PEGASUS-TIMI 54试验中患者分为,糖尿病患者(n = 6806)和非糖尿病(n = 14355)患者两个亚组,其中21162例患者1-3年的心肌梗死史与其他危险因素的患者随机分为替卡格雷(90毫克或60毫克/每日两次)或安

科学家找到治疗肥胖潜在靶点

近日,《自然》在线发表的一项研究通过分析小鼠、果蝇和人类的研究数据显示,神经降压素肽直接促进脂肪吸收和肥胖发生。

运动对糖尿病患者到底有多重要,看了你就知道

澳大利亚的一项研究表明,糖尿病患者每天早起几分钟至半小时运动相比整天躺在床上或坐在桌前更有利于控制疾病。 研究者对24名超重和肥胖且不积极锻炼的糖尿病患者进行了一系列测试。研究人员发现,当参与人员改变久坐状态,花费3分钟或更久的时间去散步或练习下蹲或抬高腿,则机体血糖、血胰岛素和c-肽含量较低。 贝克IDI心脏与糖尿病研究所研究员Paddy Dempsey博士指出,人应该运动并且永不止步。当我们经

Diabetes:多吃红葡萄和橘子,可治疗肥胖、糖尿病及CVD

Diabetes:多吃红葡萄和橘子,可治疗肥胖、糖尿病及CVD来自英国华威大学的一项新的研究发现,每日摄入红葡萄和橘子或可为肥胖、2型糖尿病和心血管疾病提供一种新的治疗方法,该研究成果已发表于Diabetes。研究人员发现,这两种水果可共同努力降低血糖水平,改善胰岛素活性,促进动脉健康。在美国,三分之一以上的成年人患有肥胖,增加了心脏病、2型糖尿病、中风和某些癌症的发生风险。9.3%的美国人患有糖

Diabetes Care:糖尿病患者控制心血管疾病危险因素可大大降低心血管疾病风险

在糖尿病(DM)患者中控制心血管疾病(CVD)的危险因素可减少CVD事件的数量,但多因素的风险因子控制的效果还不能很好地被量化。研究人员通过检测是否同时靶向血压(BP),低密度脂蛋白胆固醇(LDL-C)和糖化血红蛋白(HbA1c)治疗就可以降低美国成人糖尿病CVD事件的风险。来自美国的研究人员研究了2,018名28-86岁的成人糖尿病患者,这些参与者没有已知的CVD疾病,他们来自于社区动脉粥样硬化

Baidu
map
Baidu
map
Baidu
map